Skyepharma PLC To Present At UBS 2006 Global Specialty Pharmaceuticals Conference

LONDON, April 18 /PRNewswire-FirstCall/ -- SkyePharma PLC announces today that the Company's Chief Executive Officer, Frank Condella, will make a presentation at the UBS 2006 Global Specialty Pharmaceuticals Conference on Monday, April 24th, 2006 at 1:30 p.m. (Eastern Time) at the Grand Hyatt Hotel, New York.

The presentation will be available via a live audio webcast and you are invited to listen to the presentation by visiting and clicking on the Conferences icon in the middle right hand side of page and then follow the link for Webcast under the Global Specialty Pharmaceuticals Conference heading.

The audio webcast will also be available along with the slides of this presentation on SkyePharma's website under the Investor Relations tab.

SkyePharma PLC develops pharmaceutical products benefiting from world- leading drug delivery technologies that provide easier-to-use and more effective drug formulations. There are now eleven approved and marketed products incorporating SkyePharma's technologies in the areas of oral, injectable, inhaled and topical delivery, supported by advanced solubilisation capabilities. For more information, visit

For further information please contact: SkyePharma PLC +44 207 491 1777 Frank Condella, Chief Executive Officer Peter Laing, Director of Corporate Communications +44 207 491 5124 Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000 Tim Anderson / Mark Court

SkyePharma PLC

CONTACT: SkyePharma PLC, +44-207-491-1777, Frank Condella, Chief ExecutiveOfficer, or Peter Laing, Director of Corporate Communications,+44-207-491-5124; Sandra Haughton, US Investor Relations, +1-212-753-5780;Tim Anderson, or Mark Court, both of Buchanan Communications,+44-207-466-5000

Back to news